Inhibition of apoptosis after thymineless stress is conferred by oncogenic K-Ras in colon carcinoma cells

Clinical Cancer Research

Volumn 4, Issue 11, 1998, Pages 2841-2848

  Houghton, Janet A ^a   Ebanks, Roger ^a   Harwood, Franklin G ^a   Tillman, David M ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; GUANINE NUCLEOTIDE; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; THYMIDYLATE SYNTHASE; THYMINE;

APOPTOSIS; ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; DNA SEQUENCE; HUMAN; HUMAN CELL; ONCOGENE K RAS; POINT MUTATION; PRIORITY JOURNAL; STRESS;

APOPTOSIS; CELL DIVISION; CELL SURVIVAL; COLONIC NEOPLASMS; FAS LIGAND PROTEIN; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; HUMANS; MEMBRANE GLYCOPROTEINS; ONCOGENES; THYMIDINE; THYMIDYLATE SYNTHASE; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031753548     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Fearon, E. R., and Vogelstein, B. A. A genetic model for colorectal tumorigenesis. Cell, 61: 759-767, 1990.
2. Levine, A., Momand, J., and Finlay, C. A. The p53 tumor suppressor gene. Nature (Lond.), 351: 453-456, 1991.
3. Satoh, T., Nakafuku, M., and Kaziro, Y. Function of Ras as a molecular switch in signal transduction. J. Biol. Chem., 267: 24149-24152, 1992.
4. Bos, J. L., Fearon, E. R., Hamilton, S. R., de Vries, M. V., van Boom, J. H., van der Eb, A. J., and Vogelstein, B. Prevalence of ras gene mutations in human colorectal cancers. Nature (Lond.), 327: 293-297, 1987.
5. Forrester, K., Almoguera, C., Han, K., Grizzle, W. E., and Peruchco, M. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature (Lond.), 327: 298-303, 1987.
6. Hinds, P. W., Finlay, C. A., Quartin, R. S., Baker, S. J., Fearon, E. R., Vogelstein, B., and Levine, A. J. Mutant p53 DNA clones from human colon carcinomas cooperate with ras transforming primary rat cells: a comparison of the "hot spot" mutant p53 phenotypes. Cell Growth Differ., 1: 571-580, 1990.
7. Zambetti, G. P., Olson, D., Labow, M., and Levine, A. J. A mutant p53 protein is required for maintenance of the transformed phenotype in cells transformed with p53 plus ras cDNAs. Proc. Natl. Acad. Sci. USA, 89: 3952-3956, 1992.
8. Yin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L. C., and Wahl, G. M. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell, 70: 937-948, 1992.
9. Lowe, S. W., Ruley, E., Jacks, T., and Houseman, D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74: 957-967, 1993.
10. Bedi, A., Pasricha, P. J., Akhtar, A. J., Barber, J. P., Bedi, G. C., Giardicllo, F. M., Zehnbauer, B. A., Hamilton, S. R., and Jones, R. J. Inhibition of apoptosis during development of colorectal cancer. Cancer Res., 55: 1811-1816, 1995.
11. Bronner, M. P., Culin, C., Reed, J. C., and Furth, E. E. The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model. Am. J. Pathol., 146: 20-26, 1995.
12. Meterissian, S., and Kontagiannea, M. Fas antigen expression and function in human colorectal carcinoma. Correlation with Bcl-2 expression. Proc. Am. Assoc. Cancer. Res., 37: 15, 1996.
13. Houghton, J. A., Tillman, D. M., and Harwood, F. G. Ratio of 2′-deoxyadenosine-5′-triphosphate/thymidine-5′-triphosphate influences the commitment of human colon carcinoma cells to thymineless death. Clin. Cancer. Res., 1: 723-730, 1995.
14. Harwood, F. G., Frazier, M. W., Krajewski, S., Reed, J. C., and Houghton, J. A. Acute and delayed apoptosis induced by thymidine deprivation correlates with expression of p53 and p53-regulated genes in colon carcinoma cells. Oncogene, 12: 2057-2067, 1996.
15. Houghton, J. A., Harwood, F. G., and Tillman, D. M. Thymineless death in colon carcinoma cells is mediated via Fas signalling. Proc. Natl. Acad. Sci. USA, 94: 8144-8149, 1997.
16. McCoy, M. S., Bargmann, C. I., and Weinberg, R. A. Human colon carcinoma Ki-ras 2 oncogene and its corresponding proto-oncogene. Mol. Cell. Biol., 4: 1577-1582, 1984.
17. Suzuki, Y., Orita, M., Shiraishi, M., Hayashi, K., and Sekiya, T. Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene, 5: 1037-1043, 1990.
18. Farnsworth, C. L., Marshall, M. S., Gibbs, J. B., Stacey, D. W., and Feig, L. A. Preferential inhibition of the oncogenic form of RasH by mutations in the GAP binding/"effector" domain. Cell, 64: 625-633, 1991.
19. Marshall, M. S. The effector interactions of p21 ras. Trends Biochem. Sci., 18: 250-254, 1993.
20. Gibbs, J. B., Marshall, M. S., Scolnick, E. M., Dixon, R. A., and Vogel, U. S. Modulation guanine nucleotides bound to Ras in NIH3T cells by oncogenes, growth factors, and the GTPase activating protein (GAP). J. Biol. Chem., 265: 20437-20442, 1990.
21. Satoh, T., Nakafuku, M., Miyajima, A., and Kaziro, Y. Involvement of ras p21 protein in signal-transduction pathways from interleukin 2, interleukin 3, and granulocyte/macrophage colony-stimulating factor, but not from interleukin 4. Proc. Natl. Acad. Sci. USA, 88: 3314-3318, 1991.
22. Takuwa, N., and Takuwa, Y. Ras activity in late G1 phase required for p27kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts. Mol. Cell. Biol., 17: 5348-5358, 1997.
23. Barbacid, M. Ras genes. Annu. Rev. Biochem., 56: 779-827, 1987.
24. Kaziro, Y., Itoh, H., Kozasa, T., Nakafuku, M., and Satoh, T. Structure and function of signal-transducing GTP-binding proteins. Annu. Rev. Biochem., 60: 349-400, 1991.
25. Davis, R. J. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem., 268: 14553-14556, 1993.
26. Bollag, G., and McCormick, F. Regulators and effectors of ras proteins. Annu. Rev. Cell Biol., 7: 601-632, 1991.
27. Feig, L. A. The many roads that lead to Ras (comment). Science (Washington DC), 260: 767-768, 1993.
28. McCormick, F. Ras-related proteins in signal transduction and growth control. Mol. Reprod. Dev., 42: 500-506, 1995.
29. Kinoshita, T., Shirouzu, M., Kamiya, A., Hashimoto, K., Yokoyama, S., and Miyajima, A. Raf/MAPK and rapamycin-sensitive pathways mediate the anti-apoptotic function of p21 Ras in IL-3-dependent hematopoietic cells. Oncogene, 15: 619-627, 1997.
30. Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D., and Downward, J. Phosphatidylinositol-3-OH kinase as a direct target of Ras (see comments). Nature (Lond.), 370: 527-532, 1994.
31. Hofer, F., Fields, S., Schneider, C., and Martin, G. S. Activated Ras interacts with Ra1 guanine nucleotide dissociation stimulator. Proc. Natl. Acad. Sci. USA, 91: 11089-11093, 1994.
32. ras-generated signals towards cell growth or apoptosis is determined by protein kinase C and Bcl-2. Oncogene, 11: 1487-1498, 1995.
33. Yu, K., Chen, Y-N. P., Ravera, C. P., Bayona, W., Nalin, C. M., and Mallon, R. Ras-dependent apoptosis correlates with persistent activation of stress-activated protein kinases and induction of isoform(s) of Bcl-x. Cell Death Differ., 4: 745-755, 1997.
34. Rak, J., Mitushashi, Y., Erdos, V., Huang, S., Filmus, J., and Kerbel, R. Massive programmed cell death in intestinal epithelial cells induced by three-dimensional growth conditions: suppression by mutant c-H-ras oncogene expression. J. Cell Biol., 131: 1587-1598, 1995.
35. Kinoshita, T., Yokota, T., Arai, K., and Miyajima, A. Regulation of Bcl-2 expression by oncogenic Ras protein in hematopoietic cells. Oncogene, 10: 2207-2212, 1995.
36. Tanaka, N., Ishihara, M., Kitagawa, M., Harada, H., Kimura, T., Matsuyama, T., Lamphier, M. S., Aizawa, S., Mak, T. W., and Taniguchi, T. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell, 77: 829-839, 1994.
37. Fernandez, A., Marin, M. C., McDonnell, T., and Ananthaswamy, H. N. Differential sensitivity of normal and Ha-ras-transformed C3H mouse embryo fibroblasts to tumor necrosis factor: induction of bcl-2, c-myc, and manganese superoxide dismutase in resistant cells. Oncogene, 9: 2009-2017, 1994.
38. Kauffmann-Zeh, A., Rodriguez-Viciana, P., Ulrich, E., Gilbert, C., Coffer, P., Downward, J., and Evan, G. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature (Lond.), 385: 544-548, 1997.
39. Kennedy, S. G., Wagner, A. J., Conzen, S. D., Jordan, J., Bellacosa, A., Tsichlis, P. N., and Hay, N. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev., 11: 701-713, 1997.
40. Oltvai, Z. N., and Korsmeyer, S. J. Checkpoints of dueling dimers foil death wishes. Cell, 79: 189-192, 1994.
41. Dole, M. G., Jasty, R., Cooper, M. J., Thompson, C. B., Nunez, G., and Castle, V. P. Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res., 55: 2576-2582, 1995.
42. Chittenden, T., Harrington, E. A., O'Connor, R., Flemington, C., Lutz, R. J., Evan, G. I., and Guild, B. C. Induction of apoptosis by the Bcl-2 homologue Bak. Nature (Lond.), 374: 733-736, 1995.